BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31071683)

  • 1. Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity.
    Gawlik A; Shmoish M; Hartmann MF; Wudy SA; Olczak Z; Gruszczynska K; Hochberg Z
    Endocr Connect; 2019 Jun; 8(6):764-771. PubMed ID: 31071683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid Metabolomic Signature of Insulin Resistance in Childhood Obesity.
    Gawlik AM; Shmoish M; Hartmann MF; Wudy SA; Hochberg Z
    Diabetes Care; 2020 Feb; 43(2):405-410. PubMed ID: 31727688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity.
    Gawlik A; Shmoish M; Hartmann MF; Malecka-Tendera E; Wudy SA; Hochberg Z
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4329-4337. PubMed ID: 27504851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peer group normalization and urine to blood context in steroid metabolomics: the case of CAH and obesity.
    Vitkin E; Ben-Dor A; Shmoish M; Hartmann MF; Yakhini Z; Wudy SA; Hochberg Z
    Steroids; 2014 Oct; 88():83-9. PubMed ID: 25042470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
    Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
    Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.
    Troisi J; Pierri L; Landolfi A; Marciano F; Bisogno A; Belmonte F; Palladino C; Guercio Nuzio S; Campiglia P; Vajro P
    Nutrients; 2017 May; 9(5):. PubMed ID: 28492501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.
    Mager DR; Mazurak V; Rodriguez-Dimitrescu C; Vine D; Jetha M; Ball G; Yap J
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):517-28. PubMed ID: 23223552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
    Amin S; El Amrousy D; Elrifaey S; Gamal R; Hodeib H
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):117-121. PubMed ID: 28991837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome.
    Troisi J; Belmonte F; Bisogno A; Pierri L; Colucci A; Scala G; Cavallo P; Mandato C; Di Nuzzi A; Di Michele L; Delli Bovi AP; Guercio Nuzio S; Vajro P
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30691143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
    Peng L; Wu S; Zhou N; Zhu S; Liu Q; Li X
    BMC Pediatr; 2021 Mar; 21(1):122. PubMed ID: 33711964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
    Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
    Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
    Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.